Circle of Willis atherosclerosis is a risk factor for sporadic Alzheimer's disease

被引:237
作者
Roher, AE
Esh, C
Kokjohn, TA
Kalback, W
Luehrs, DC
Seward, JD
Sue, LI
Beach, TG
机构
[1] Sun Hlth Res Inst, Longtine Ctr Mol Biol & Genet, Sun City, AZ 85351 USA
[2] Midwestern Univ, Sch Osteopath Med, Dept Microbiol, Glendale, AZ USA
[3] Sun Hlth Res Inst, Dept Epidemiol & Biostat, Sun City, AZ USA
[4] Sun Hlth Res Inst, WH Civin Lab Neuropathol, Sun City, AZ USA
关键词
atherosclerosis; circle of Willis; Alzheimer's disease; brain hypoperfusion;
D O I
10.1161/01.ATV.0000095973.42032.44
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives - We conducted a quantitative investigation of brain arterial atherosclerotic damage and its relationship to sporadic Alzheimer's disease ( AD). Methods and Results - Fifty- four consecutive autopsy cases, 32 AD and 22 nondemented control subjects, were examined to establish the degree of arterial stenosis. Vessel external and lumenal area measurements were taken from 3- mm arterial cross- sections to calculate a stenosis index. AD patient circle of Willis arteries possessed a significant degree of stenosis as a consequence of multiple and severe atherosclerotic lesions. These lesions were significantly more severe in AD cases than in age- matched controls ( P < 0.0001), and the number of stenoses and the index of occlusion ( R = 0.67; P < 0.00001) were positively correlated. In addition, the index of stenosis significantly correlated with the following measures of AD neuropathological lesions: total plaque score, neuritic plaque score, neurofibrillary tangle score, Braak stage score, and white matter rarefaction score. Conclusions - Our study reveals an association between severe circle of Willis atherosclerosis and sporadic AD that should be considered a risk factor for this dementia. These observations strongly suggest that atherosclerosis- induced brain hypoperfusion contributes to the clinical and pathological manifestations of AD.
引用
收藏
页码:2055 / 2062
页数:8
相关论文
共 75 条
[31]   Hypertension is related to cognitive impairment - A 20-year follow-up of 999 men [J].
Kilander, L ;
Nyman, H ;
Boberg, M ;
Hansson, L ;
Lithell, H .
HYPERTENSION, 1998, 31 (03) :780-786
[32]   Apolipoprotein E ε4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease [J].
Kivipelto, M ;
Helkala, EL ;
Laakso, MP ;
Hänninen, T ;
Hallikainen, M ;
Alhainen, K ;
Iivonen, S ;
Mannermaa, A ;
Tuomilehto, J ;
Nissinen, A ;
Soininen, H .
ANNALS OF INTERNAL MEDICINE, 2002, 137 (03) :149-155
[33]   Midlife vascular risk factors and late-life mild cognitive impairment -: A population-based study [J].
Kivipelto, M ;
Helkala, EL ;
Hänninen, T ;
Laakso, MP ;
Hallikainen, M ;
Alhainen, K ;
Soininen, H ;
Tuomilehto, J ;
Nissinen, A .
NEUROLOGY, 2001, 56 (12) :1683-1689
[34]   Hypertension and hypercholesterolaemia as risk factors for Alzheimer's disease - Potential for pharmacological intervention [J].
Kivipelto, M ;
Laakso, MP ;
Tuomilehto, J ;
Nissinen, A ;
Soininen, H .
CNS DRUGS, 2002, 16 (07) :435-444
[35]   Cardiovascular risk factors and cognitive decline in middle-aged adults [J].
Knopman, D ;
Boland, LL ;
Mosley, T ;
Howard, G ;
Liao, D ;
Szklo, M ;
McGovern, P ;
Folsom, AR .
NEUROLOGY, 2001, 56 (01) :42-48
[36]   INCREASING PREVALENCE OF OVERWEIGHT AMONG US ADULTS - THE NATIONAL-HEALTH AND NUTRITION EXAMINATION SURVEYS, 1960 TO 1991 [J].
KUCZMARSKI, RJ ;
FLEGAL, KM ;
CAMPBELL, SM ;
JOHNSON, CL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (03) :205-211
[37]   Elevated low-density lipoprotein in Alzheimer's disease correlates with brain Aβ 1-42 levels [J].
Kuo, YM ;
Emmerling, MR ;
Bisgaier, CL ;
Essenburg, AD ;
Lampert, HC ;
Drumm, D ;
Roher, AE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 252 (03) :711-715
[38]   Midlife blood pressure and dementia: the Honolulu-Asia aging study [J].
Launer, LJ ;
Ross, GW ;
Petrovitch, H ;
Masaki, K ;
Foley, D ;
White, LR ;
Havlik, RJ .
NEUROBIOLOGY OF AGING, 2000, 21 (01) :49-55
[39]   Demonstrating the case that AD is a vascular disease: epidemiologic evidence [J].
Launer, LJ .
AGEING RESEARCH REVIEWS, 2002, 1 (01) :61-77
[40]   Cholesterol and neuropathologic markers of AD - A population-based autopsy study [J].
Launer, LJ ;
White, LR ;
Petrovitch, H ;
Ross, GW ;
Curb, JD .
NEUROLOGY, 2001, 57 (08) :1447-1452